Webinar - Water for injection
16th May 2018, 10am
Recent changes to the European Pharmacopoeia Monograph has left many Pharmaceutical companies unclear as to which process to adopt in water for injection (WFI) production.
James Steptoe, Veolia Water Technologies, is delivering a webinar on 'Water for injection production with a Reverse Osmosis-based system'. James will be reviewing these changes and comparing the different approaches available for WFI production.
What will be covered?
- An overview of WFI
- WFI - Quality of different purified water standards
- Recent changes to the European Pharmacopoeia Monograph and the impact on the market
- Distillation versus Reverse Osmosis - the benefits and implications of both methods
- Making the right choice of WFI production methods - finding the right balance between cost and risk
Registration for this webinar is now available so if you're interested, you can sign up below.
Traditional distillation versus alternative purification processes
With recent regulatory changes made by the European Pharmacopoeia, we've answered the key questions facing the market at a time where change is possible. Decision makers are tasked with the option of continuing with traditional methods or turning to newly approved techniques as their preferred choice in providing pure distilled water for injections.
Presentation on WFI production
Our Business Development Manager James Steptoe is delivering a presentation at Making Pharmaceuticals on 25th April at 16:55 in Room C. He will be discussing water for injection and the impact the recent changes to the European Pharmacopoeia Monograph are having on the market. You can pre-book an appointment with one of our experts or just come and visit us as you pass by our stand.